Pharmacologic therapy of atrial flutter

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 10, 1996, Pages 1008-1012

  Campbell, Ronald W F ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

atrioventricular conduction; medical cardioversion; pacing; thromboembolism

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; LIDOCAINE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL;

ANTICOAGULANT THERAPY; ATRIOVENTRICULAR CONDUCTION; CATHETER ABLATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART PACING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOFREQUENCY; SINUS RHYTHM; THROMBOEMBOLISM;

EID: 0029814914     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00475.x     Document Type: Conference Paper

References (32)

1. Olshansky B, Wilber DJ, Hariman RJ: Atrial flutter - Update on the mechanism and treatment. PACE 1992;15:2308-2335.
2. Klein GJ, Guiraudon GM, Sharma AD, et al: Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol 1986;57:587-591.
3. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The "Sicilian Gambit": A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Eur Heart J 1991;12:1112-1131.
4. Saumarez RC, Parker J, Camm J: Geometrically accurate activation mapping of the atrioventricular node region during surgery. J Am Coll Cardiol 1992;19: 601-606.
5. Cosio FG, Giocolea A, Lopez-Gil M, et al: Atrial endocardial mapping in the rare form of atrial flutter. Am J Cardiol 1990;66:715-720.
6. Allessie MA, Janse MJ: Atrial fibrillation: Is our electrophysiological understanding on the right wave-length? In Campbell RWF, Janse JM, eds: Cardiac Arrhythmias: The Management of Atrial Fibrillation. Springer-Verlag, Berlin, 1992, pp. 17-26.
7. Robertson CE, Miller HC: Extreme tachycardia complicating the use of disopyramide in atrial flutter. Br Heart J 1980;44:602-603.
8. London F, Howell M: Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis. Am Heart J 1954;48:152-156.
9. Feld GK, Venkatesh N, Singh BN: Pharmacologic conversion and suppression of experimental canine atrial flutter: Differing effects of d-sotalol, quinidine and lidocaine and significance of changes in refractoriness and conduction. Circulation 1986;74:197-204.
10. Yamashita T, Inoue H, Nozaki A, et al: Role of anisotropy in determining the selective action of antiarrhythmics in atrial flutter in the dog. Cardiovasc Res 1992; 26:244-249.
11. Inoue H, Yamashita T, Usui M, et al: Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: Comparative study of disopyramide, flecainide, and E-4031. Cardiovasc Res 1991; 25:223-229.
12. McAlister HF, Luke RA, Whitlock RM, et al: Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. J Thorac Cardiovasc Surg 1990;99:911-918.
13. Antman EM, Beamer AD, Cantillon C, et al: Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990;15:698-707.
14. Suttorp MJ, Kingma JH, Lie-A-Huen L, et al: Intravenous flecainide versus verapamil for conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.
15. Bianconi L, Boccadamo R, Pappalardo A, et al: Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989;64:335-338.
16. Cohen-Solal A, Juliard JM, Jaeger P, et al: Reduction of auricular fibrillation and tachycardia using intravenous flecainide. Arch Mal Coeur Vaiss 1987;80: 1290-1296.
17. Garson A, Bink-Boelkens M, Hesslein PS, et al: Atrial flutter in the young: A collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871-878.
18. Delia Bella P, Marenzi G, Tondo C, et al: Usefulness of excitable gap and pattern of resetting in atrial flutter for determining re-entry circuit location. Am J Cardiol 1991;68:492-497.
19. Fujimoto T, Inoue T, Ogawa H, et al: The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy. Jpn Circ J 1989;53:237-244.
20. Heldal M, Orning OM: Effects of flecainide on termination of atrial flutter by rapid atrial pacing. Eur Heart J 1993;14:421-424.
21. Hu J, Mitchell LB, Duff HJ, et al: Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter. Am J Cardiol 1992; 70:463-467.
22. Hoffmann E, Steinbeck G: Electrophysiology of supraventricular tachycardia (atrial fibrillation/atrial flutter). Z Gesamte Inn Med Grenzgeb 1993;48:439-445.
23. Case CL, Gillette PC, Zeigler VL, et al: Successful treatment of congenital atrial flutter with antitachycardia pacing. PACE 1990;13:571-573.
24. Lewis T: Diseases of the Heart. Fourth Edition. MacMillan, London, 1948.
25. Cosio FG, Goicolea A, Lopez-Gill M, et al: Catheter ablation of atrial flutter circuits. PACE 1993;16:637-642.
26. Calkins H, Leon AR, Deam AG, et al: Catheter ablation of atrial flutter using radiofrequency energy. Am J Cardiol 1994;73:353-356.
27. Suttorp MJ, Polak PE, van't Hof A, et al: Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter. Am J Cardiol 1992;69:417-419.
28. Arnold AZ, Mick MJ, Mazurek RP, et al: Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-855.
29. Santiago D, Warshofsky M, Giuseppe LM, et al: Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transoesophageal echocardiographic study. J Am Coll Cardiol 1994;24:159-164.
30. Feltes TF, Friedman RA: Transoesophageal echocardiographic detection of atrial thrombi in patients with non fibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol 1994;24:1365-1370.
31. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323: 1505-1511.
32. Singer DE, Hughes RA, Gress DR, et al: The effect of aspirin on the risk of stroke in patients with non-rheumatic atrial fibrillation. Am Heart J 1992;124: 1567-1573.